Basic Information
ID: ALA3779604
Type: Functional
Description: Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levels
Format: BAO_0000357
Organism: Homo sapiens
Target: Somatostatin receptor 3(ALA2028)
Document: ALA3774320
Antagonist activity at human somatostatin receptor type 3 assessed as inhibition of cAMP levels: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3779604
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 398.51 | 4.91 | 4.91 |
| 494.53 | 4.30 | 4.30 |
| 416.50 | 5.05 | 5.05 |
| 495.52 | 3.70 | 3.70 |
| 412.54 | 5.09 | 5.09 |
| 404.56 | 5.29 | 5.29 |
| 378.52 | 4.54 | 4.54 |
| 456.63 | 5.71 | 5.71 |
| 416.50 | 5.05 | 5.05 |
| 416.50 | 5.05 | 5.05 |
| 432.96 | 5.57 | 5.57 |
| 423.52 | 4.78 | 4.78 |
| 423.52 | 4.78 | 4.78 |
| 412.54 | 5.22 | 5.22 |
| 466.51 | 5.93 | 5.93 |
| 414.51 | 4.62 | 4.62 |
| 428.54 | 4.92 | 4.92 |
| 428.54 | 4.92 | 4.92 |
| 482.51 | 5.81 | 5.81 |
| 482.51 | 5.81 | 5.81 |
| 474.61 | 6.58 | 6.58 |
| 442.52 | 4.61 | 4.61 |
| 476.60 | 4.32 | 4.32 |
| 434.49 | 5.19 | 5.19 |
| 434.49 | 5.19 | 5.19 |
| 430.53 | 5.06 | 5.06 |
| 430.53 | 5.06 | 5.06 |
| 430.53 | 5.06 | 5.06 |
| 412.54 | 5.22 | 5.22 |
| 416.50 | 5.05 | 5.05 |
| 398.51 | 4.91 | 4.91 |
| 417.49 | 4.45 | 4.45 |
| 404.54 | 4.97 | 4.97 |
| 438.98 | 5.63 | 5.63 |
| 418.57 | 5.28 | 5.28 |
| 454.60 | 6.13 | 6.13 |
| 437.55 | 5.39 | 5.39 |
| 399.50 | 4.31 | 4.31 |
| 399.50 | 4.31 | 4.31 |
| 399.50 | 4.31 | 4.31 |
| 400.49 | 3.70 | 3.70 |
| 400.49 | 3.70 | 3.70 |
| 405.53 | 4.37 | 4.37 |
| 405.53 | 4.37 | 4.37 |
| 417.49 | 4.45 | 4.45 |
| 433.94 | 4.96 | 4.96 |
| 429.52 | 4.32 | 4.32 |
| 476.54 | 4.16 | 4.16 |
| 476.54 | 4.16 | 4.16 |
| 477.53 | 3.56 | 3.56 |
| 477.53 | 3.56 | 3.56 |
| 495.52 | 3.70 | 3.70 |
| 507.56 | 3.57 | 3.57 |
| 507.56 | 3.57 | 3.57 |